AIF-regulated oxidative phosphorylation supports lung cancer development

Area of Science:

• Oncology
• Cellular Metabolism
• Mitochondrial Biology

Background:

• Cancer cells exhibit altered metabolism, notably the Warburg effect, favoring glycolysis over oxidative phosphorylation (OXPHOS) to meet biosynthetic demands.
• The apoptosis-inducing factor (AIF) plays a role in cellular processes, but its specific impact on cancer metabolism and progression is not fully understood.

Purpose of the Study:

• To investigate the role of AIF in Kras-driven lung cancer development and progression.
• To elucidate the metabolic and bioenergetic consequences of AIF deletion in lung cancer cells.

Main Methods:

• Utilized a Kras^G12D-driven mouse lung cancer model with AIF gene deletion.
• Analyzed cellular metabolism, focusing on oxidative phosphorylation (OXPHOS) and glycolysis.
• Assessed tumor onset, malignant progression, and animal survival rates.
• Investigated the effect of AIF re-expression in knockout models.
• Correlated AIF expression with patient prognosis in non-small cell lung cancer.

Main Results:

• AIF deletion in Kras^G12D mice led to delayed tumor onset, reduced malignant progression, and increased survival.
• AIF deficiency induced OXPHOS deficiency and a metabolic shift towards glycolysis.
• Paradoxically, this Warburg-like metabolic shift resulted in a growth disadvantage for lung cancer cells.
• Restoration of AIF, even with abrogated apoptotic function, restored OXPHOS and reduced survival advantage.
• High AIF expression in human non-small cell lung cancer patients correlated with poor prognosis.

Conclusions:

• AIF is crucial for maintaining mitochondrial respiration and OXPHOS in lung cancer cells.
• AIF promotes lung cancer progression, and its expression is linked to poor patient outcomes.
• Targeting AIF-regulated mitochondrial respiration presents a potential therapeutic strategy for lung cancer.